CFTR and urea cycle disorder: Sodium 4-phenylbutyrate (PBA), an otherwise approved drug for urea cycle disorders, proved to be a clinically relevant chemical chaperone restoring chloride transport of the mutated ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) [11].